Article Text

Download PDFPDF
Prevalence of Chlamydia trachomatis IgG antibodies in antenatal patients from Trinidad
  1. A Eley1,
  2. H A Hemeg1,
  3. I Geary1,
  4. S S Ramsewak2,
  5. A Herring3,
  6. E O Caul3
  1. 1Division of Genomic Medicine, University of Sheffield Medical School, Sheffield S10 2RX, UK
  2. 2Department of Clinical Surgical Sciences, The University of the West Indies, St Augustine, Trinidad
  3. 3Genitourinary Infections Reference Laboratory, Bristol Public Health Laboratory, Bristol BS2 8EL, UK
  1. Dr A Eley, Division of Genomic Medicine, Floor F, University of Sheffield Medical School, Beech Hill Road, Sheffield S 10 2RX, UKa.r.eley{at}

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Editor,—A recent study in Jamaica by Dowe et al using cell culture and a direct fluorescence assay (DFA) showed a prevalence of Chlamydia trachomatis infection in 47% of gynaecological patients.1 Unfortunately, there are no comparable data for cell culture and DFA in Trinidad. Moreover, we cannot find any reports on serological studies for C trachomatis IgG antibody in the West Indies. In an attempt to shed more light on prevalence of C trachomatis IgG antibody in pregnant women in Trinidad, we collected 56 serum specimens (mean age of patients 27 years) with ethics committee approval from one clinic at the general hospital, Port of Spain. As well as testing these sera …

View Full Text